Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Nasopharyngeal Carcinoma

Clinical trial condition

Metastatic Nasopharyngeal Carcinoma

Explore clinical trials studying Metastatic Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Nasopharyngeal Carcinoma trial results

Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

NCT06029270

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +14 more
Locations: Kaiser Permanente Dublin Dublin, California, United States

Kaiser Permanente-Fremont Fremont, California, United States

Kaiser Permanente Fresno Orchard Plaza Fresno, California, United States

Kaiser Permanente-Fresno Fresno, California, United States

View all 88 locations

View Trial Details

Recruiting

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

NCT06802835

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +14 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Metastatic Nasopharyngeal Carcinoma

NCT06886347

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +12 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Not Yet Recruiting

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

NCT06331845

Conditions: Carcinoma, Head and Neck Neoplasms, Intermittent Systematic Chemotherapy, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

NCT05484375

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +12 more
Locations: Not specified

View Trial Details

Completed

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

NCT01392235

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +13 more
Locations: Department of Medical Oncology, Cancer Center, Sun Yet-sen University Guangzhou, Guangdong, China

View Trial Details